S&P 500   3,141.84 (-0.13%)
DOW   27,939.80 (-0.27%)
QQQ   204.69 (-0.15%)
AAPL   265.37 (-1.97%)
FB   202.48 (+0.71%)
MSFT   151.84 (+0.06%)
GOOGL   1,351.49 (+0.90%)
AMZN   1,757.83 (+0.36%)
CGC   21.09 (+13.08%)
NVDA   212.84 (+0.32%)
MU   46.81 (-2.34%)
BABA   200.95 (-0.47%)
GE   11.03 (-0.63%)
AMD   39.24 (-0.98%)
ACB   2.54 (+4.53%)
F   9.01 (-0.11%)
NFLX   307.13 (-0.07%)
BAC   33.51 (-0.48%)
GILD   66.96 (-0.18%)
DIS   146.85 (-0.55%)
S&P 500   3,141.84 (-0.13%)
DOW   27,939.80 (-0.27%)
QQQ   204.69 (-0.15%)
AAPL   265.37 (-1.97%)
FB   202.48 (+0.71%)
MSFT   151.84 (+0.06%)
GOOGL   1,351.49 (+0.90%)
AMZN   1,757.83 (+0.36%)
CGC   21.09 (+13.08%)
NVDA   212.84 (+0.32%)
MU   46.81 (-2.34%)
BABA   200.95 (-0.47%)
GE   11.03 (-0.63%)
AMD   39.24 (-0.98%)
ACB   2.54 (+4.53%)
F   9.01 (-0.11%)
NFLX   307.13 (-0.07%)
BAC   33.51 (-0.48%)
GILD   66.96 (-0.18%)
DIS   146.85 (-0.55%)
S&P 500   3,141.84 (-0.13%)
DOW   27,939.80 (-0.27%)
QQQ   204.69 (-0.15%)
AAPL   265.37 (-1.97%)
FB   202.48 (+0.71%)
MSFT   151.84 (+0.06%)
GOOGL   1,351.49 (+0.90%)
AMZN   1,757.83 (+0.36%)
CGC   21.09 (+13.08%)
NVDA   212.84 (+0.32%)
MU   46.81 (-2.34%)
BABA   200.95 (-0.47%)
GE   11.03 (-0.63%)
AMD   39.24 (-0.98%)
ACB   2.54 (+4.53%)
F   9.01 (-0.11%)
NFLX   307.13 (-0.07%)
BAC   33.51 (-0.48%)
GILD   66.96 (-0.18%)
DIS   146.85 (-0.55%)
S&P 500   3,141.84 (-0.13%)
DOW   27,939.80 (-0.27%)
QQQ   204.69 (-0.15%)
AAPL   265.37 (-1.97%)
FB   202.48 (+0.71%)
MSFT   151.84 (+0.06%)
GOOGL   1,351.49 (+0.90%)
AMZN   1,757.83 (+0.36%)
CGC   21.09 (+13.08%)
NVDA   212.84 (+0.32%)
MU   46.81 (-2.34%)
BABA   200.95 (-0.47%)
GE   11.03 (-0.63%)
AMD   39.24 (-0.98%)
ACB   2.54 (+4.53%)
F   9.01 (-0.11%)
NFLX   307.13 (-0.07%)
BAC   33.51 (-0.48%)
GILD   66.96 (-0.18%)
DIS   146.85 (-0.55%)
Log in

NASDAQ:PDEX - Pro-Dex Stock Price, Forecast & News

$15.64
-0.24 (-1.51 %)
(As of 12/9/2019 12:31 PM ET)
Today's Range
$15.64
Now: $15.64
$15.64
50-Day Range
$11.63
MA: $13.47
$15.90
52-Week Range
$10.37
Now: $15.64
$17.95
Volume100 shs
Average Volume23,420 shs
Market Capitalization$62.09 million
P/E Ratio17.07
Dividend YieldN/A
Beta1.51
Pro-Dex, Inc., together with its subsidiaries, designs, develops, and manufactures powered surgical instruments, dental instruments, and rotary air motors worldwide. It also manufactures plastic injection molds for various industries; and shavers and machined parts. In addition, it provides engineering, and quality and regulatory consulting services. The company offers its products under the name of Pro-Dex.Pro-Dex, Inc. sells its medical device products primarily to original equipment manufacturers; and dental products to dental product distributors. Its products are used in hospitals, medical engineering labs, scientific research facilities, and high-tech manufacturing operations. Pro-Dex, Inc. was founded in 1978 and is headquartered in Irvine, California.

Industry, Sector and Symbol

Industry Surgical & medical instruments
Sub-IndustryN/A
SectorMedical
Current SymbolNASDAQ:PDEX
CUSIPN/A
Phone949-769-3200

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$27.17 million
Cash Flow$1.10 per share
Book Value$4.14 per share

Profitability

Net Income$4.15 million

Miscellaneous

Employees80
Market Cap$62.09 million
Next Earnings Date2/6/2020 (Estimated)
OptionableNot Optionable

Receive PDEX News and Ratings via Email

Sign-up to receive the latest news and ratings for PDEX and its competitors with MarketBeat's FREE daily newsletter.


Pro-Dex (NASDAQ:PDEX) Frequently Asked Questions

What is Pro-Dex's stock symbol?

Pro-Dex trades on the NASDAQ under the ticker symbol "PDEX."

How were Pro-Dex's earnings last quarter?

Pro-Dex Inc (NASDAQ:PDEX) issued its earnings results on Thursday, August, 30th. The medical instruments supplier reported $0.22 EPS for the quarter, topping the Zacks' consensus estimate of $0.06 by $0.16. Pro-Dex had a net margin of 14.19% and a return on equity of 22.60%. View Pro-Dex's Earnings History.

When is Pro-Dex's next earnings date?

Pro-Dex is scheduled to release their next quarterly earnings announcement on Thursday, February 6th 2020. View Earnings Estimates for Pro-Dex.

What price target have analysts set for PDEX?

1 equities research analysts have issued 1 year price targets for Pro-Dex's shares. Their forecasts range from $20.00 to $20.00. On average, they expect Pro-Dex's stock price to reach $20.00 in the next year. This suggests a possible upside of 27.9% from the stock's current price. View Analyst Price Targets for Pro-Dex.

What is the consensus analysts' recommendation for Pro-Dex?

1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Pro-Dex in the last year. There are currently 1 buy rating for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Pro-Dex.

Has Pro-Dex been receiving favorable news coverage?

Media stories about PDEX stock have been trending somewhat negative this week, according to InfoTrie. The research firm identifies negative and positive press coverage by analyzing more than six thousand blog and news sources. The firm ranks coverage of publicly-traded companies on a scale of negative five to five, with scores nearest to five being the most favorable. Pro-Dex earned a daily sentiment score of -1.7 on InfoTrie's scale. They also gave media coverage about the medical instruments supplier a news buzz of 0.0 out of 10, meaning that recent press coverage is extremely unlikely to have an effect on the company's share price in the next several days. View News Stories for Pro-Dex.

Are investors shorting Pro-Dex?

Pro-Dex saw a decline in short interest in the month of November. As of November 15th, there was short interest totalling 5,000 shares, a decline of 39.0% from the October 31st total of 8,200 shares. Based on an average daily volume of 14,000 shares, the short-interest ratio is currently 0.4 days. Currently, 0.2% of the shares of the company are short sold. View Pro-Dex's Current Options Chain.

Who are some of Pro-Dex's key competitors?

What other stocks do shareholders of Pro-Dex own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Pro-Dex investors own include KEMET (KEM), Micron Technology (MU), NVIDIA (NVDA), Bank of America (BAC), Arrowhead Pharmaceuticals (ARWR), Marvell Technology Group (MRVL), Alibaba Group (BABA), Cigna (CI), salesforce.com (CRM) and Walt Disney (DIS).

Who are Pro-Dex's key executives?

Pro-Dex's management team includes the folowing people:
  • Mr. Richard Lee Van Kirk Jr., CEO, Pres, COO & Director (Age 58)
  • Mrs. Alisha K. Charlton, CFO & Corp. Sec. (Age 49)

Who are Pro-Dex's major shareholders?

Pro-Dex's stock is owned by a number of of retail and institutional investors. Top institutional investors include Squarepoint Ops LLC (0.47%) and Hancock Whitney Corp (0.26%). Company insiders that own Pro-Dex stock include Alisha Charlton, David Hovda, Kirk Richard Lee Van Jr, Nicholas John Swenson, Raymond E Cabillot and William James Farrell III. View Institutional Ownership Trends for Pro-Dex.

Which major investors are buying Pro-Dex stock?

PDEX stock was purchased by a variety of institutional investors in the last quarter, including Hancock Whitney Corp and Squarepoint Ops LLC. Company insiders that have bought Pro-Dex stock in the last two years include Kirk Richard Lee Van Jr and William James Farrell III. View Insider Buying and Selling for Pro-Dex.

How do I buy shares of Pro-Dex?

Shares of PDEX can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

What is Pro-Dex's stock price today?

One share of PDEX stock can currently be purchased for approximately $15.64.

How big of a company is Pro-Dex?

Pro-Dex has a market capitalization of $62.09 million and generates $27.17 million in revenue each year. Pro-Dex employs 80 workers across the globe.View Additional Information About Pro-Dex.

What is Pro-Dex's official website?

The official website for Pro-Dex is http://www.pro-dex.com/.

How can I contact Pro-Dex?

Pro-Dex's mailing address is 2361 MCGAW AVENUE, IRVINE CA, 92614. The medical instruments supplier can be reached via phone at 949-769-3200 or via email at [email protected]


MarketBeat Community Rating for Pro-Dex (NASDAQ PDEX)

Community Ranking:  2.3 out of 5 (star star)
Outperform Votes:  80 (Vote Outperform)
Underperform Votes:  94 (Vote Underperform)
Total Votes:  174
MarketBeat's community ratings are surveys of what our community members think about Pro-Dex and other stocks. Vote "Outperform" if you believe PDEX will outperform the S&P 500 over the long term. Vote "Underperform" if you believe PDEX will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 12/9/2019 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel